Novel target for reducing flare in giant cell arteritis

An investigational monoclonal antibody that inhibits GM-CSF receptor alpha shows promise, researchers say
Medicom Staff writer

AusDoc brings you the latest news from the American College of Rheumatology virtual congress 2020.

A new option for treating giant cell arteritis might be on the horizon, a conference has heard.